5 stocks to research for your investing homework

Five companies I am thinking of adding to my portfolio but require further research.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The last few months have seen several previously high achieving mid-cap stocks fall from grace amidst disappointing earnings expectations and macroeconomic uncertainty. Such dramatic shifts in sentiment can provide opportunities for brave investors who do their homework. Here are introductions to five stocks that I think look interesting right now but require further research.

Capilano Honey Ltd (ASX: CZZ)

I used to own shares in Capilano but am starting to get interested again as the price is 30% off recent highs. The company owns what is in my opinion one of the best brands in Australia and dominates the domestic retail honey market. There is the potential for significant uplift in sales to China over future years but this needs to be weighed up against supply risks including unfavourable weather and disease. Trading on a mid-teens price-to-earnings ratio (PER), I feel that the market is currently valuing this company on the conservative side.

Mayne Pharma Group Ltd (ASX: MYX)

Generic drug company Mayne Pharma has grown rapidly over the last few years. It has developed drug delivery technologies over 30 years and its strategy is to apply these to acquired drug portfolios. This appeals to me, as does Mayne's potential to achieve economies of scale as it increases manufacturing throughput. On the other hand, I suspect that competition will erode prices over time and the company has recently been confronted by the U.S. Department of Justice over pricing. However, this enquiry relates to just a small proportion of the company's revenue base and so the recent share price weakness could be a buying opportunity.

Vocus Group Ltd (ASX: VOC)

Vocus shares have fallen over 50% in recent months following leadership changes and as the ongoing switchover to the NBN casts uncertainty over the future of the telco industry. But a significant part of Vocus' business is from the corporate sector which is less likely to be impacted by the NBN. Furthermore, the NBN simply replaces Telstra's copper network and so essentially Vocus is just switching from one monopoly supplier to another. I think the risk of customer churn during this process is relatively low as it will happen largely in the background from the customer's point of view.

TPG Telecom Ltd (ASX: TPM)

TPG is in a similar situation to Vocus regarding the NBN as it also has a significant corporate arm. Under the leadership of founder and major shareholder, David Teoh, TPG has generated significant shareholder value over many years. The company recently announced that it is expanding into Singapore which strikes me as sensible given investment opportunities in Australia are perhaps more limited today than they once were. TPG is priced at a slight premium compared to Vocus, but neither look excessively expensive considering their track records.

Blackmores Limited (ASX: BKL)

Blackmores  generates outstanding returns on capital thanks to the power of its brand which enables it to command premium prices for what are essentially generic products. After an outstanding 2016, Blackmores has hit a speed bump this year as changes to Chinese export channels impacted sales in the first quarter. Like Capilano, China potentially represents a large opportunity for Blackmores over many years and I expect sales to the Middle Kingdom to resume their upward trajectory over time. However, the stock still looks a little pricey based on my expectations for 2017.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia owns shares of Capilano Honey Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »